The future of islet transplantation beyond the BLA approval: challenges and opportunities

This opinion paper explores the path forward for islet transplantation as a cell therapy for type 1 diabetes, following the Biologics License Application (BLA) approval. The authors review key challenges and opportunities that lie ahead. After a brief overview of the history of human islet transplan...

Description complète

Détails bibliographiques

Auteurs principaux:	Yong Wang, James McGarrigle, Jenny Cook, Peter Rios, Giovanna La Monica, Yingying Chen, Wei Wei, Jose Oberholzer
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2025-03-01
Collection:	Frontiers in Transplantation
Sujets:	islet transplant type I diabetes federal food and drug administration biologics license application (BLA) LANTIDRA
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/frtra.2025.1522409/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!